Stavroula K. Hatzios
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Stavroula K. Hatzios has a total of 155 co-authors. Here are the top co-authors by number of shared publications:
- Carolyn R. Bertozzi
Department of Chemistry, Stanford University, Stanford, CA 94305, USA
5 shared publications Elizabeth M. Gordon
Department of Molecular, Cellular, and Developmental Biology, Yale University, New Haven, CT 06520, USA; Microbial Sciences Institute, Yale University, West Haven, CT 06516, USA
4 shared publicationsYekaterina Kovalyova
Affiliations Department of Molecular, Cellular, and Developmental Biology, Yale University, New Haven, Connecticut, United States of America, Microbial Sciences Institute, Yale University, West Haven, Connecticut, United States of America, Department of Chemistry, Yale University, New Haven, Connecticut, United States of America
4 shared publicationsAnna B. Seminara
Department of Microbial Pathogenesis, Yale University School of Medicine, New Haven, CT 06536, USA; Microbial Sciences Institute, Yale University, West Haven, CT 06516, USA
3 shared publicationsDaniel G. Dumitrescu
Department of Molecular, Cellular, and Developmental Biology, Yale University, New Haven, CT, 06520, USA; Department of Chemistry, Yale University, New Haven, CT, 06520, USA; Microbial Sciences Institute, Yale University, West Haven, CT, 06516, USA
3 shared publications- Eranthie Weerapana
Department of Chemistry, Boston College, Chestnut Hill, USA
3 shared publications
Latest Publications
- Open Access
- 19 February 2026
- Published by American Society for Microbiology in Journal of Bacteriology
- Vol. 208 (2) , e0045725
Managing dangerous liaisons: lessons from Helicobacter pylori for understanding bacterial carcinogenesis
As the first bacterium to be deemed a class I carcinogen by the World Health Organization in 1994, Helicobacter pylori has paved the way for studying complex host-pathogen interactions. While 1982 marked the discovery of this helical-shaped microorganism found in gastric biopsies by Drs. Robin Warren and Barry Marshall, it took years to link H. pylori infection to gastric inflammation, ulcers, and adenocarcinoma (recognized by a Nobel Prize in 2005). Further investigations into how H. pylori colonizes the stomach, the identification of key virulence factors (such as VacA, CagA, and outer membrane proteins), and global epidemiological studies solidified the impact of H. pylori on gastric disease. This review details the seminal discovery of H. pylori and subsequent work that cemented its status as a microbial carcinogen. Because chronic H. pylori infection and progressive changes to the tissue environment prior to cancer development can span years/decades, studying H. pylori pathogenesis has been challenging. We focus on the importance of using animal models, in particular mouse models, to recapitulate hallmarks of H. pylori- driven human disease. Finally, we highlight recent findings illustrating how H. pylori has adapted to survive and utilize oxidative stress induced during infection, which potentiates cancer development. Due to the long-lasting nature of H. pylori infection and associated remodeling of the host environment that, in turn, promotes carcinogenesis, H. pylori stands as a model organism for understanding other chronic bacterial infections in humans and pathogen-associated malignancies.
- 19 February 2026
- Published by American Society for Microbiology in Journal of Bacteriology
- Vol. 208 (2) , e0045725
Open AccessManaging dangerous liaisons: lessons from Helicobacter pylori for understanding bacterial carcinogenesis
As the first bacterium to be deemed a class I carcinogen by the World Health Organization in 1994, Helicobacter pylori has paved the way for studying complex host-pathogen interactions. While 1982 marked the discovery of this helical-shaped microorganism found in gastric biopsies by Drs. Robin Warren and Barry Marshall, it took years to link H. pylori infection to gastric inflammation, ulcers, and adenocarcinoma (recognized by a Nobel Prize in 2005). Further investigations into how H. pylori colonizes the stomach, the identification of key virulence factors (such as VacA, CagA, and outer membrane proteins), and global epidemiological studies solidified the impact of H. pylori on gastric disease. This review details the seminal discovery of H. pylori and subsequent work that cemented its status as a microbial carcinogen. Because chronic H. pylori infection and progressive changes to the tissue environment prior to cancer development can span years/decades, studying H. pylori pathogenesis has been challenging. We focus on the importance of using animal models, in particular mouse models, to recapitulate hallmarks of H. pylori- driven human disease. Finally, we highlight recent findings illustrating how H. pylori has adapted to survive and utilize oxidative stress induced during infection, which potentiates cancer development. Due to the long-lasting nature of H. pylori infection and associated remodeling of the host environment that, in turn, promotes carcinogenesis, H. pylori stands as a model organism for understanding other chronic bacterial infections in humans and pathogen-associated malignancies.
- Open Access
- 4 August 2025
- Published by Elsevier in Cell Host & Microbe
- Vol. 33 (8) , 1321-1332.e9
Metabolic cross-feeding of a dietary antioxidant enhances anaerobic energy metabolism by human gut bacteria
- 4 August 2025
- Published by Elsevier in Cell Host & Microbe
- Vol. 33 (8) , 1321-1332.e9
Open AccessMetabolic cross-feeding of a dietary antioxidant enhances anaerobic energy metabolism by human gut bacteria
- 10 March 2025
- Published by Elsevier in Cell Chemical Biology
- Vol. 32 (3) , 486-497.e7
An affinity-based depletion strategy for evaluating the effects of ergothioneine on bacterial physiology
- 10 March 2025
- Published by Elsevier in Cell Chemical Biology
- Vol. 32 (3) , 486-497.e7
An affinity-based depletion strategy for evaluating the effects of ergothioneine on bacterial physiology
- 24 December 2024
- Published by Elsevier in Current Opinion in Chemical Biology
- Vol. 84, 102565
Microbial metabolism of host-derived antioxidants
- 24 December 2024
- Published by Elsevier in Current Opinion in Chemical Biology
- Vol. 84, 102565
Microbial metabolism of host-derived antioxidants
- 24 December 2024
- Published by Springer Nature in Nature Chemical Biology
- Vol. 21 (1) , 6-15
Thoughts for the future
- 24 December 2024
- Published by Springer Nature in Nature Chemical Biology
- Vol. 21 (1) , 6-15
Thoughts for the future
- Open Access
- 26 July 2023
- Published by Public Library of Science (PLoS) in PLOS Pathogens
- Vol. 19 (7) , e1011526
Isotope tracing reveals bacterial catabolism of host-derived glutathione during Helicobacter pylori infection
Mammalian cells synthesize the antioxidant glutathione (GSH) to shield cellular biomolecules from oxidative damage. Certain bacteria, including the gastric pathogen Helicobacter pylori, can perturb host GSH homeostasis. H. pylori infection significantly decreases GSH levels in host tissues, which has been attributed to the accumulation of reactive oxygen species in infected cells. However, the precise mechanism of H. pylori-induced GSH depletion remains unknown, and tools for studying this process during infection are limited. We developed an isotope-tracing approach to quantitatively monitor host-derived GSH in H. pylori-infected cells by mass spectrometry. Using this method, we determined that H. pylori catabolizes reduced GSH from gastric cells using γ-glutamyl transpeptidase (gGT), an enzyme that hydrolyzes GSH to glutamate and cysteinylglycine (Cys-Gly). gGT is an established virulence factor with immunomodulatory properties that is required for H. pylori colonization in vivo. We found that H. pylori internalizes Cys-Gly in a gGT-dependent manner and that Cys-Gly production during H. pylori infection is coupled to the depletion of intracellular GSH from infected cells. Consistent with bacterial catabolism of host GSH, levels of oxidized GSH did not increase during H. pylori infection, and exogenous antioxidants were unable to restore the GSH content of infected cells. Altogether, our results indicate that H. pylori-induced GSH depletion proceeds via an oxidation-independent mechanism driven by the bacterial enzyme gGT, which fortifies bacterial acquisition of nutrients from the host. Additionally, our work establishes a method for tracking the metabolic fate of host-derived GSH during infection.
- 26 July 2023
- Published by Public Library of Science (PLoS) in PLOS Pathogens
- Vol. 19 (7) , e1011526
Open AccessIsotope tracing reveals bacterial catabolism of host-derived glutathione during Helicobacter pylori infection
Mammalian cells synthesize the antioxidant glutathione (GSH) to shield cellular biomolecules from oxidative damage. Certain bacteria, including the gastric pathogen Helicobacter pylori, can perturb host GSH homeostasis. H. pylori infection significantly decreases GSH levels in host tissues, which has been attributed to the accumulation of reactive oxygen species in infected cells. However, the precise mechanism of H. pylori-induced GSH depletion remains unknown, and tools for studying this process during infection are limited. We developed an isotope-tracing approach to quantitatively monitor host-derived GSH in H. pylori-infected cells by mass spectrometry. Using this method, we determined that H. pylori catabolizes reduced GSH from gastric cells using γ-glutamyl transpeptidase (gGT), an enzyme that hydrolyzes GSH to glutamate and cysteinylglycine (Cys-Gly). gGT is an established virulence factor with immunomodulatory properties that is required for H. pylori colonization in vivo. We found that H. pylori internalizes Cys-Gly in a gGT-dependent manner and that Cys-Gly production during H. pylori infection is coupled to the depletion of intracellular GSH from infected cells. Consistent with bacterial catabolism of host GSH, levels of oxidized GSH did not increase during H. pylori infection, and exogenous antioxidants were unable to restore the GSH content of infected cells. Altogether, our results indicate that H. pylori-induced GSH depletion proceeds via an oxidation-independent mechanism driven by the bacterial enzyme gGT, which fortifies bacterial acquisition of nutrients from the host. Additionally, our work establishes a method for tracking the metabolic fate of host-derived GSH during infection.
- 22 June 2023
- Published by Springer Nature in Nature Chemical Biology
- Vol. 19 (12) , 1436-1437
Moonlighting in the membrane
- 22 June 2023
- Published by Springer Nature in Nature Chemical Biology
- Vol. 19 (12) , 1436-1437
Moonlighting in the membrane
- 17 May 2023
- Published by Elsevier in Current Opinion in Chemical Biology
- Vol. 75, 102322
Emerging roles of low-molecular-weight thiols at the host–microbe interface
- 17 May 2023
- Published by Elsevier in Current Opinion in Chemical Biology
- Vol. 75, 102322
Emerging roles of low-molecular-weight thiols at the host–microbe interface
- 16 February 2023
- Published by Wiley in Israel Journal of Chemistry
- Vol. 63 (3-4)
Activity‐based Tools for Interrogating Host Biology During Infection
Host cells sense and respond to pathogens by dynamically regulating cell signaling. The rapid modulation of signaling pathways is achieved by post‐translational modifications (PTMs) that can alter protein structure, function, and/or binding interactions. By using chemical probes to broadly profile changes in enzyme function or side‐chain reactivity, activity‐based protein profiling (ABPP) can reveal PTMs that regulate host–microbe interactions. While ABPP has been widely utilized to uncover microbial mechanisms of pathogenesis, in this review, we focus on more recent applications of this technique to the discovery of host PTMs and enzymes that modulate signaling within infected cells. Collectively, these advances underscore the importance of ABPP as a tool for interrogating the host response to infection and identifying potential targets for host‐directed therapies.
- 16 February 2023
- Published by Wiley in Israel Journal of Chemistry
- Vol. 63 (3-4)
Activity‐based Tools for Interrogating Host Biology During Infection
Host cells sense and respond to pathogens by dynamically regulating cell signaling. The rapid modulation of signaling pathways is achieved by post‐translational modifications (PTMs) that can alter protein structure, function, and/or binding interactions. By using chemical probes to broadly profile changes in enzyme function or side‐chain reactivity, activity‐based protein profiling (ABPP) can reveal PTMs that regulate host–microbe interactions. While ABPP has been widely utilized to uncover microbial mechanisms of pathogenesis, in this review, we focus on more recent applications of this technique to the discovery of host PTMs and enzymes that modulate signaling within infected cells. Collectively, these advances underscore the importance of ABPP as a tool for interrogating the host response to infection and identifying potential targets for host‐directed therapies.